# Reply to Gringras et al. Comment on “Paditz et al. The Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review. Children 2025, 12, 648”

**Authors:** Osman S. Ipsiroglu, Hans-Jürgen Gober

PMC · DOI: 10.3390/children12111564 · Children · 2025-11-18

## Full-text entities

- **Diseases:** Non-Organic Sleep Disorders (MESH:D009102), Autism Spectrum Disorder (MESH:D000067877)
- **Chemicals:** Melatonin (MESH:D008550)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12651868/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12651868/full.md

---
Source: https://tomesphere.com/paper/PMC12651868